California CDI Essential Alternatives Drug List (Español) pdf opens in a new window
A Spanish version (part 2 of 2) of a payer's California CDI Essential Alternatives drug list showing brand-name drugs mapped to excluded alternative products (organized alphabetically). Includes language assistance and nondiscrimination statements. This part contains many drug mapping lines but no explicit coverage criteria, dates, or policy number.
No material changes — this Spanish-language part lists brand drugs mapped to excluded alternatives and preferred alternatives and does not introduce coverage rule changes.
Policy type and scope
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.